| 查看: 352 | 回复: 1 | ||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | ||
yin198716新虫 (正式写手)
|
[求助]
求助翻译
|
|
| A question of high priority is whether the approved antiangiogenic regimes are optimally used in terms of dosing, duration, and combination therapy. The role of VEGF (receptor) inhibitors in micrometast atic disease in adjuvant settings (e.g.,upon resection of the primary tumor) will require further research given the paucity of available preclinical data and suitable animal models. |
回复此楼
nwsuafliu
木虫 (著名写手)
- 翻译EPI: 144
- 应助: 42 (小学生)
- 金币: 2406.9
- 散金: 1449
- 红花: 18
- 帖子: 1437
- 在线: 315.6小时
- 虫号: 136928
- 注册: 2005-12-17
- 专业: 作物分子育种
2楼2013-01-31 15:37:08
